2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one

C124H149Cl4F6N27O7 — CID 157455094

IUPAC2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one
SMILESCC(=O)Nc1nc(C)c2c(n1)CCN(C1CCC(CN)(c3cccc(Cl)c3)CC1)C2=O.Cc1cccc(C2(CN)CCC(N3CCn4c(nnc4C(F)(F)F)C3=O)CC2)c1.Cc1cccc(C2(CN)CCC(N3CCn4nc(C(F)(F)F)nc4C3=O)CC2)c1.Cc1nc(N)nc2c1C(=O)N(C1CCC(CN)(c3cccc(Cl)c3)CC1)CC2.NCC1(c2cccc(Cl)c2)CCC(N2CCc3ccccc3C2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCn3ncnc3C2=O)CC1
InChIInChI=1S/C23H28ClN5O2.C22H25ClN2O.C21H26ClN5O.2C20H24F3N5O.C18H22ClN5O/c1-14-20-19(28-22(26-14)27-15(2)30)8-11-29(21(20)31)18-6-9-23(13-25,10-7-18)16-4-3-5-17(24)12-16;23-18-6-3-5-17(14-18)22(15-24)11-8-19(9-12-22)25-13-10-16-4-1-2-7-20(16)21(25)26;1-13-18-17(26-20(24)25-13)7-10-27(19(18)28)16-5-8-21(12-23,9-6-16)14-3-2-4-15(22)11-14;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-26-18(28)20(21,22)23;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-18(26-28)20(21,22)23;19-14-3-1-2-13(10-14)18(11-20)6-4-15(5-7-18)23-8-9-24-16(17(23)25)21-12-22-24/h3-5,12,18H,6-11,13,25H2,1-2H3,(H,26,27,28,30);1-7,14,19H,8-13,15,24H2;2-4,11,16H,5-10,12,23H2,1H3,(H2,24,25,26);2*2-4,11,15H,5-10,12,24H2,1H3;1-3,10,12,15H,4-9,11,20H2
InChIKeyBTGJSRUMDQDVBF-UHFFFAOYSA-N
MW2385.54 g/mol
LogP18.30
Rot. Bonds19

About 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one

2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one (PubChem CID 157455094) has the molecular formula C124H149Cl4F6N27O7 and a molecular weight of 2385.54 g/mol. Its IUPAC name is 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one.

Molecular Properties

Compound Name2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one
PubChem CID157455094
Molecular FormulaC124H149Cl4F6N27O7
Molecular Weight2385.54 g/mol
Exact Mass2382.08
IUPAC Name2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one
SMILESCC(=O)Nc1nc(C)c2c(n1)CCN(C1CCC(CN)(c3cccc(Cl)c3)CC1)C2=O.Cc1cccc(C2(CN)CCC(N3CCn4c(nnc4C(F)(F)F)C3=O)CC2)c1.Cc1cccc(C2(CN)CCC(N3CCn4nc(C(F)(F)F)nc4C3=O)CC2)c1.Cc1nc(N)nc2c1C(=O)N(C1CCC(CN)(c3cccc(Cl)c3)CC1)CC2.NCC1(c2cccc(Cl)c2)CCC(N2CCc3ccccc3C2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCn3ncnc3C2=O)CC1
InChIInChI=1S/C23H28ClN5O2.C22H25ClN2O.C21H26ClN5O.2C20H24F3N5O.C18H22ClN5O/c1-14-20-19(28-22(26-14)27-15(2)30)8-11-29(21(20)31)18-6-9-23(13-25,10-7-18)16-4-3-5-17(24)12-16;23-18-6-3-5-17(14-18)22(15-24)11-8-19(9-12-22)25-13-10-16-4-1-2-7-20(16)21(25)26;1-13-18-17(26-20(24)25-13)7-10-27(19(18)28)16-5-8-21(12-23,9-6-16)14-3-2-4-15(22)11-14;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-26-18(28)20(21,22)23;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-18(26-28)20(21,22)23;19-14-3-1-2-13(10-14)18(11-20)6-4-15(5-7-18)23-8-9-24-16(17(23)25)21-12-22-24/h3-5,12,18H,6-11,13,25H2,1-2H3,(H,26,27,28,30);1-7,14,19H,8-13,15,24H2;2-4,11,16H,5-10,12,23H2,1H3,(H2,24,25,26);2*2-4,11,15H,5-10,12,24H2,1H3;1-3,10,12,15H,4-9,11,20H2
InChIKeyBTGJSRUMDQDVBF-UHFFFAOYSA-N
XLogP18.30
TPSA476.79 Ų
H-Bond Donors8
H-Bond Acceptors27
Rotatable Bonds19
Heavy Atoms168
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002385.54
LogP ≤ 518.30
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1027

Analyze 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The IUPAC name of 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one (CID 157455094) is 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one.
What is the SMILES notation for 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The canonical SMILES for 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one is CC(=O)Nc1nc(C)c2c(n1)CCN(C1CCC(CN)(c3cccc(Cl)c3)CC1)C2=O.Cc1cccc(C2(CN)CCC(N3CCn4c(nnc4C(F)(F)F)C3=O)CC2)c1.Cc1cccc(C2(CN)CCC(N3CCn4nc(C(F)(F)F)nc4C3=O)CC2)c1.Cc1nc(N)nc2c1C(=O)N(C1CCC(CN)(c3cccc(Cl)c3)CC1)CC2.NCC1(c2cccc(Cl)c2)CCC(N2CCc3ccccc3C2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCn3ncnc3C2=O)CC1.
What is the InChIKey of 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The InChIKey is BTGJSRUMDQDVBF-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H28ClN5O2.C22H25ClN2O.C21H26ClN5O.2C20H24F3N5O.C18H22ClN5O/c1-14-20-19(28-22(26-14)27-15(2)30)8-11-29(21(20)31)18-6-9-23(13-25,10-7-18)16-4-3-5-17(24)12-16;23-18-6-3-5-17(14-18)22(15-24)11-8-19(9-12-22)25-13-10-16-4-1-2-7-20(16)21(25)26;1-13-18-17(26-20(24)25-13)7-10-27(19(18)28)16-5-8-21(12-23,9-6-16)14-3-2-4-15(22)11-14;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-26-18(28)20(21,22)23;1-13-3-2-4-14(11-13)19(12-24)7-5-15(6-8-19)27-9-10-28-16(17(27)29)25-18(26-28)20(21,22)23;19-14-3-1-2-13(10-14)18(11-20)6-4-15(5-7-18)23-8-9-24-16(17(23)25)21-12-22-24/h3-5,12,18H,6-11,13,25H2,1-2H3,(H,26,27,28,30);1-7,14,19H,8-13,15,24H2;2-4,11,16H,5-10,12,23H2,1H3,(H2,24,25,26);2*2-4,11,15H,5-10,12,24H2,1H3;1-3,10,12,15H,4-9,11,20H2.
What are the key properties of 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one has a molecular weight of 2385.54 g/mol, XLogP of 18.30, 19 rotatable bonds, 8 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5-one;2-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3,4-dihydroisoquinolin-1-one;7-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;N-[6-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-4-methyl-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-2-yl]acetamide;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-2-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-8-one;7-[4-(aminomethyl)-4-(3-methylphenyl)cyclohexyl]-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-one is sourced from PubChem (CID 157455094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).